CSPC Pharma (01093) issued a total of 9.462 million restricted shares.
Sinopharm Group (01093) announced that on April 2, 2026, the company granted a total of 9.462 million restricted shares to 488 selected participants in accordance with the 2018 stock incentive plan.
CSPC PHARMA (01093) announced that on April 2, 2026, the company granted a total of 9.462 million restricted shares to 488 selected participants in accordance with the 2018 stock incentive plan.
Related Articles
On April 2nd, LIANLIAN (02598) spent HK$5.176 million to repurchase 918,500 shares.
The 2026 Xiaopeng MONA M03 officially launched with a starting price of 119,800 yuan.
CH CITY INFRA(02349): Chen Kaixin appointed as independent non-executive director
On April 2nd, LIANLIAN (02598) spent HK$5.176 million to repurchase 918,500 shares.
The 2026 Xiaopeng MONA M03 officially launched with a starting price of 119,800 yuan.
CH CITY INFRA(02349): Chen Kaixin appointed as independent non-executive director
RECOMMEND
Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026
Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026
Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026
